Hagens Berman Blog

Whistleblower News: Indivior, Danske Bank, Uber

by HB Whistleblower Legal Team

04/12/2019

Contact Us

British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.

The federal government is charging the maker of the addiction drug Suboxone with fraud and conspiracy in marketing the drug to doctors.

Share prices for the British drugmaker Indivior plunged today on the London Stock Exchange. The drop came on news that the U.S. Justice Department indicted the company on fraud and conspiracy charges. Indivior makes the drug Suboxone, widely used to treat people suffering from opioid addiction. Federal prosecutors now claim the company falsely marketed Suboxone as safer and less prone to abuse than cheaper generic drugs. read more »

Danske Bank auditor EY reported to fraud squad over 2014 report

Accountant EY’s audit of scandal-hit Danske Bank came under scrutiny on Friday as Danish authorities asked the state prosecutor for financial fraud to investigate the matter. read more »

Uber Discloses Investigation Into Allegations of Improper Payments

The ride-sharing company said prosecutors requested information related to allegations of payments to police in Indonesia

The Justice Department in 2017 took preliminary steps to investigate whether managers at Uber violated the U.S. Foreign Corrupt Practices Act, which bans the use of bribes to foreign officials to get or keep business. read more »